On the basis of these observations, HSD could act as an inflammatory trigger that may overcome immunosuppressive conditions associated with tumor microenvironment such as the expression of checkpoint inhibitors and down-regulation of major histocompatibility complex I (MHC-I) molecules. This evidence concerns the gene CHST3 and neoplasm.